CN103251847B - Traditional Chinese medicine for treating leucoderma - Google Patents
Traditional Chinese medicine for treating leucoderma Download PDFInfo
- Publication number
- CN103251847B CN103251847B CN201310219676.5A CN201310219676A CN103251847B CN 103251847 B CN103251847 B CN 103251847B CN 201310219676 A CN201310219676 A CN 201310219676A CN 103251847 B CN103251847 B CN 103251847B
- Authority
- CN
- China
- Prior art keywords
- grams
- parts
- chinese medicine
- traditional chinese
- treating leucoderma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating leucoderma. The traditional Chinese medicine is characterized by being prepared from the following crude drugs in parts by weight: 30 parts of sorbaria sorbifolia, 18 parts of rhodomyrtus tomentosa hassk, 2 parts of stigma croci, 12 parts of liana, 8 parts of olive, 10 parts of viola arcuata, 10 parts of scented daphne leaves and 10 parts of fructus cannabis. Clinical trials prove that the traditional Chinese medicine can be used for safely and effectively treating leucoderma.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to one and treat leukodermic Chinese medicine.
Background technology
Leucoderma disease is the general designation to the some diseases taking leukoderma as cardinal symptom medically.Because its morbidity occupies without fixed place, there is ailment said due to cold or exposure feature, be in fashion which position, which position and turn white, therefore named " vitiligo ".Vitiligo is a kind of posteriority constitutional depigmentation disease, because hypofunction or the forfeiture of enzyme system in the melanocyte of skin and hair follicle cause, verify through Chinese medicine research center, although it does not ache and does not itch, also do not infect, even seldom heredity, but because of its impact attractive in appearance, so cause very large psychological burden and stress to patient.Current medicine is cured the symptoms, not the disease, and conventional has dependency and a toxic and side effects.Therefore research and develop the leukodermic Chinese medicine of a kind of safe and effective treatment very with practical value.
Summary of the invention
The present invention aims to provide one and treats leukodermic Chinese medicine, by selecting suitable medical material and proportioning thereof, reaches the leukodermic object of safe and effective healing.
In order to achieve the above object, the present invention is by the following technical solutions:
One is treated leukodermic Chinese medicine, it is characterized in that, it is to be prepared from by the medical material of following weight portion:
30 parts of mountain Sorghum vulgare Pers., 18 parts of Radix Rhodomyrtis, 2 parts of Stigma Crocis, 12 parts of Sinomenium acutum, 8 parts of olives, 10 parts of Viola arcuata, 10 parts of Folium daphnes odoraes, 10 parts of Fructus Cannabiss.
Below in conjunction with clinical experiment data declaration beneficial effect of the present invention:
1, physical data
80 routine leukodermic out-patients are collected, wherein male 45 examples, female's 35 examples between year February altogether in inventor in October, 2009-2012.Be divided at random: treatment group 50 examples, matched group 30 examples.The data such as two groups of sexes, age, the state of an illness there are no significant difference, has comparability.
2, test method
The oral Bai Lixiu of matched group, uses 1 month course for the treatment of according to its description.
The capsule that the oral the present invention for the treatment of group makes according to specific embodiment 1, every bu is taken for 2 times, 1 month course for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Recovery from illness: clinical symptoms all disappears.Take a turn for the better: clinical symptom relief.Invalid: clinical symptoms is without being clearly better or increasing the weight of.
3.2 treatment statistical results are in table 1.
Table 1 liang group curative effect comparison
| Group | n | Recovery from illness | Take a turn for the better | Invalid | Untoward reaction example | Total effective rate (%) |
| Treatment group | 50 | 36 | 10 | 4 | 0（0%） | 92% |
| Matched group | 30 | 2 | 13 | 15 | 3（10%） | 50% |
Visible, the medicine that the preferred embodiment for the present invention makes can safe and effective treatment vitiligo.
Detailed description of the invention
In order to understand better and to implement the present invention, further illustrate the present invention below in conjunction with specific embodiment.
Specific embodiment 1
Take 30 grams of mountain Sorghum vulgare Pers., 18 grams of Radix Rhodomyrtis, 2 grams of Stigma Crocis, 12 grams of Sinomenium acutum, 8 grams of olives, 10 grams of Viola arcuata, 10 grams of Folium daphnes odoraes, 10 grams of Fructus Cannabiss; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, incapsulate shell, must meet the capsule of one day consumption of normal adult.
Be used for the treatment of vitiligo.Oral, every bu is taken for twice sooner or later.
Claims (1)
1. the leukodermic Chinese medicine for the treatment of, is characterized in that, it is to be prepared from by the medical material of following weight: 30 grams of mountain Sorghum vulgare Pers., 18 grams of Radix Rhodomyrtis, 2 grams of Stigma Crocis, 12 grams of Sinomenium acutum, 8 grams of olives, 10 grams of Viola arcuata, 10 grams of Folium daphnes odoraes, 10 grams of Fructus Cannabiss; The preparation method of described Chinese medicine is: take 30 grams of mountain Sorghum vulgare Pers., 18 grams of Radix Rhodomyrtis, 2 grams of Stigma Crocis, 12 grams of Sinomenium acutum, 8 grams of olives, 10 grams of Viola arcuata, 10 grams of Folium daphnes odoraes, 10 grams of Fructus Cannabiss; Add 8 times of water gagings, decoct 1.5 hours, filter; Filtering residue adds 6 times of water gagings, decocts 1 hour, filters; Merging filtrate, concentrated, dry, incapsulate shell, must meet the capsule of one day consumption of normal adult.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310219676.5A CN103251847B (en) | 2013-06-05 | 2013-06-05 | Traditional Chinese medicine for treating leucoderma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310219676.5A CN103251847B (en) | 2013-06-05 | 2013-06-05 | Traditional Chinese medicine for treating leucoderma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103251847A CN103251847A (en) | 2013-08-21 |
| CN103251847B true CN103251847B (en) | 2014-10-22 |
Family
ID=48956280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310219676.5A Expired - Fee Related CN103251847B (en) | 2013-06-05 | 2013-06-05 | Traditional Chinese medicine for treating leucoderma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103251847B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893558A (en) * | 2014-03-14 | 2014-07-02 | 于波 | Traditional Chinese medicine for treating leucoderma |
| CN108542945A (en) * | 2018-07-24 | 2018-09-18 | 甘肃岷海医药科技有限公司 | It is a kind of to be used to treat external use liquid dressing of skin diseases and preparation method thereof and application method |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098311A (en) * | 1994-02-02 | 1995-02-08 | 李庆和 | Treat leukodermic Chinese medicine Baiyuwan pill |
| CN1253785A (en) * | 1998-11-13 | 2000-05-24 | 安国良 | Spot-removing pill |
| CN101549144A (en) * | 2009-05-14 | 2009-10-07 | 吐尔逊·乌甫尔 | Oral preparation for treating vitiligo |
| CN101897933A (en) * | 2010-07-18 | 2010-12-01 | 陈福正 | Chinese patent medicament for treating leucoderma |
| CN102008703A (en) * | 2010-12-16 | 2011-04-13 | 西安谦坤商务咨询管理有限公司 | External-application Chinese medicinal composition for treating leucoderma |
| CN102416079A (en) * | 2011-11-29 | 2012-04-18 | 渠淑敏 | Chinese patent medicine for treating leucoderma |
| CN102895310A (en) * | 2012-11-15 | 2013-01-30 | 孙德臣 | External preparation for treating leucoderma |
-
2013
- 2013-06-05 CN CN201310219676.5A patent/CN103251847B/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098311A (en) * | 1994-02-02 | 1995-02-08 | 李庆和 | Treat leukodermic Chinese medicine Baiyuwan pill |
| CN1253785A (en) * | 1998-11-13 | 2000-05-24 | 安国良 | Spot-removing pill |
| CN101549144A (en) * | 2009-05-14 | 2009-10-07 | 吐尔逊·乌甫尔 | Oral preparation for treating vitiligo |
| CN101897933A (en) * | 2010-07-18 | 2010-12-01 | 陈福正 | Chinese patent medicament for treating leucoderma |
| CN102008703A (en) * | 2010-12-16 | 2011-04-13 | 西安谦坤商务咨询管理有限公司 | External-application Chinese medicinal composition for treating leucoderma |
| CN102416079A (en) * | 2011-11-29 | 2012-04-18 | 渠淑敏 | Chinese patent medicine for treating leucoderma |
| CN102895310A (en) * | 2012-11-15 | 2013-01-30 | 孙德臣 | External preparation for treating leucoderma |
Non-Patent Citations (10)
| Title |
|---|
| 中医药治疗白癜风的概况;穆怀萍;《云南中医中药杂志》;20121231;第33卷(第8期);71-73 * |
| 中医药治疗白癜风近况;尹平;《云南中医杂志》;19941231;第15卷(第5期);36-38 * |
| 中药内服联合其他外治法治疗白癜风;周守红等;《中国美容医学》;20070228;第16卷(第2期);275-277 * |
| 周守红等.中药内服联合其他外治法治疗白癜风.《中国美容医学》.2007,第16卷(第2期),275-277. |
| 尹平.中医药治疗白癜风近况.《云南中医杂志》.1994,第15卷(第5期),36-38. |
| 白癜风的中医治疗及研究进展;谢韶琼;《中医杂志》;20000131;第41卷(第1期);53-55 * |
| 白癜风的中西医治疗研究进展;胡蓉等;《现代中西医结合杂志》;20070531;第16卷(第14期);2017-2019 * |
| 穆怀萍.中医药治疗白癜风的概况.《云南中医中药杂志》.2012,第33卷(第8期),71-73. |
| 胡蓉等.白癜风的中西医治疗研究进展.《现代中西医结合杂志》.2007,第16卷(第14期),2017-2019. |
| 谢韶琼.白癜风的中医治疗及研究进展.《中医杂志》.2000,第41卷(第1期),53-55. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103251847A (en) | 2013-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103251847B (en) | Traditional Chinese medicine for treating leucoderma | |
| CN103565938B (en) | A kind of Chinese medicine compound for the treatment of infantile eczema and preparation method thereof | |
| CN101588810B (en) | Composition comprising trachelospermi caulis and pyrola japonica extracts for the treatment and prevention of inflammatory diseases | |
| CN103169875B (en) | Traditional Chinese medicine for treating asthma | |
| CN103446317A (en) | Traditional Chinese medicine for curing senile dementia | |
| CN103446394A (en) | Traditional Chinese medicine for treating acne | |
| CN105497291A (en) | Medicine composition for treating schizophrenia | |
| CN101028311B (en) | Use of selaginella tamariscina | |
| CN103239622B (en) | Chinese traditional medicine for treating acne | |
| CN104524085A (en) | Drug for treatment of primary dysmenorrhea | |
| CN103446293A (en) | Traditional Chinese medicine for curing leucoderma | |
| CN104147168B (en) | A kind of Chinese medicine for treating pressure ulcer | |
| CN103446296A (en) | Traditional Chinese medicine for curing hyperlipidemia | |
| CN103285262B (en) | Traditional Chinese medicine for treating hemicrania | |
| Solanki et al. | REVIEW ON COMPARATIVE STUDY OF VARIOUS PHARMACOLOGICAL SCREENING OF GLYCYRRHIZA GLABRA LINN. IN RELATION WITH AYURVEDIC DOCUMENTED LITERATURE | |
| CN103446416A (en) | Traditional Chinese medicine for curing migraine | |
| CN103055149B (en) | Traditional Chinese medicine for treating pressure sores | |
| CN103446371A (en) | Traditional Chinese medicine for curing asthma | |
| CN103705677B (en) | A kind of Chinese medicine for the treatment of facial neuritis | |
| CN103169889B (en) | Traditional Chinese medicine for treating depressive disorder | |
| CN102727657B (en) | Medicament for treating neurasthenia | |
| CN103285224A (en) | Traditional Chinese medicine for treating lymphoid tuberculosis | |
| CN103446372A (en) | Traditional Chinese medicine for curing tuberculosis | |
| CN103446301A (en) | Traditional Chinese medicine for treating rheumatism | |
| CN103446415A (en) | Traditional Chinese medicine for curing depression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: HEBEI UNIVERSITY OF ENGINEERING Free format text: FORMER OWNER: GAO ZHONGQING Effective date: 20140918 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Geng Jianfang Inventor after: Xiao Yuesheng Inventor after: Shi Yu Inventor after: Gao Zhongqing Inventor before: Gao Zhongqing |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 255400 ZIBO, SHANDONG PROVINCE TO: 056038 HANDAN, HEBEI PROVINCE Free format text: CORRECT: INVENTOR; FROM: GAO ZHONGQING TO: GENG JIANFANG XIAO YUESHENG SHI YU GAO ZHONGQING |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140918 Address after: 056038 Guangming South Street, Hebei, Handan, No. 199 Applicant after: Hebei University of Engineering Address before: 255400 Zibo City, Linzi Province, Samsung water city 9-2-401 Applicant before: Gao Zhongqing |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141022 Termination date: 20150605 |
|
| EXPY | Termination of patent right or utility model |